Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue

Basude, 2000, Influence of environmental conditions on a new surfactant-based contrast agent: ST68, Ultrasound Med. Biol., 26, 621, 10.1016/S0301-5629(99)00151-9 Basude, 2001, Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages, Ultrasonics, 39, 437, 10.1016/S0041-624X(01)00080-4 Bekeredjian, 2006, Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications, Ultraschall Med., 27, 134, 10.1055/s-2005-858993 Brown, 2004, Exploiting tumor hypoxia in cancer treatment, Nat. Rev. Cancer, 4, 437, 10.1038/nrc1367 Brown, 2007, Tumor hypoxia in cancer therapy, Methods Enzymol., 435, 297 Cavalieri, 2008, Polymer microbubbles as diagnostic and therapeutic gas delivery device, Chem. Mater., 20, 3254, 10.1021/cm703702d Cavalli, 2009, Ultrasound-mediated oxygen delivery from chitosan nanobubbles, Int. J. Pharm., 378, 215, 10.1016/j.ijpharm.2009.05.058 Cavalli, 2009, Preparation and characterization of dextran nanobubbles for oxygen delivery, Int. J. Pharm., 382, 160, 10.1016/j.ijpharm.2009.07.010 Davidson, 2012, Future applications of contrast echocardiography, Heart, 98, 246, 10.1136/heartjnl-2011-300737 Eisenbrey, 2009, Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic acid contrast agents, Ultrasonics, 49, 628, 10.1016/j.ultras.2009.03.003 Eisenbrey, 2010, Contrast-enhanced ultrasound for molecular imaging of angiogenesis, Eur. J. Nucl. Med. Mol. Imaging, 37, S138, 10.1007/s00259-010-1449-6 Eisenbrey, 2010, Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound triggered drug delivery, J. Control Release, 143, 38, 10.1016/j.jconrel.2009.12.021 Escoffre, 2011, Doxorubicin delivery into tumor cells with ultrasound and microbubbles, Mol. Pharm., 8, 799, 10.1021/mp100397p Ferrara, 2007, Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery, Annu. Rev. Biomed. Eng., 9, 415, 10.1146/annurev.bioeng.8.061505.095852 Feshitan, 2009, Microbubble size isolation by differential centrifugation, J. Colloid Interface Sci., 329, 316, 10.1016/j.jcis.2008.09.066 Forsberg, 1997, Quantitative acoustic characterization of a new surfactant-based ultrasound contrast agent, Ultrasound Med. Biol., 23, 1201, 10.1016/S0301-5629(97)00078-1 Forsberg, 1999, Effect of filling gases on the backscatter from contrast microbubbles: theory and in vivo measurements, Ultrasound Med. Biol., 25, 1203, 10.1016/S0301-5629(99)00079-4 Forsberg, 2010, Preclinical acute toxicology study of surfactant-stabilized ultrasound contrast agents in adult rats, Int. J. Toxicol., 29, 32, 10.1177/1091581809354342 Goldberg, 2001 Hodgkiss, 1987, Rapid-mixing studies of radiosensitivity with thiol-depleted mammalian cells, Int. J. Radiot. Biol. Relat. Stud. Phys. Chem. Med., 52, 735, 10.1080/09553008714552241 Klegerman, 2010, Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics, J. Control Release, 142, 326, 10.1016/j.jconrel.2009.10.037 Kwan, 2012, Theranostic oxygen delivery using ultrasound and microbubbles, Theranostics, 2, 1174, 10.7150/thno.4410 Kuwahara, 1998, Experimental infusion phlebitis: tolerance osmolarity of peripheral venous endothelial cells, Nutrition, 14, 496, 10.1016/S0899-9007(98)00037-9 Miller, 2004, Contrast echocardiography: new agents, Ultrasound Med. Biol., 30, 425, 10.1016/j.ultrasmedbio.2003.12.002 Oeffinger, 2004, Design and acoustic characterization of a nano-scale ultrasound contrast agent, J. Ultrasound Med., 23, S77 Polizzotti, 2014, Optimization and characterization of stable lipid-based, oxygen filled microbubbles by mixture design, J. Biomed. Mater. Res. B Appl. Biomater., 102, 1148, 10.1002/jbm.b.33096 Postema, 2006, Nitric oxide delivery by ultrasonic cracking: some limitations, Ultrasonics, 44, e109, 10.1016/j.ultras.2006.06.003 Richard, 1999, Angiogenesis: how a tumor adapts to hypoxia, Biochem. Biophys. Res. Commun., 266, 718, 10.1006/bbrc.1999.1889 Rockwell, 2009, Hypoxia and radiation therapy: past history, ongoing research, and future promise, Curr. Col. Med., 9, 442, 10.2174/156652409788167087 Seo, 2010, Microfluidic assembly of monodisperse, nanoparticle-incoporated perfluorocarbon microbubbles for medical imaging and therapy, Langmuir, 26, 13855, 10.1021/la102272d Solis, 2010, Preserving enhancement in freeze-dried contrast agent ST68: examination of excipients, Int. J. Pharm., 396, 30, 10.1016/j.ijpharm.2010.06.004 Swanson, 2010, Injectable oxygen delivery based on protein-shelled microbubbles, Nano Life, 1, 215, 10.1142/S1793984410000195 Swanson, 2010, Phospholipid-stabilized microbubble foam for injectable oxygen delivery, Langmuir, 26, 15726, 10.1021/la1029432 Tong, 2013, Mesenchymal stem cell transplantation enhancement in myocardial infarction rat model under ultrasound combined with nitric oxide microbubbles, PLoS One, 8, e80186, 10.1371/journal.pone.0080186 Wang, 2010, Preparation of nanobubbles for ultrasound imaging and intracellular drug delivery, Int. J. Pharm, 384, 148, 10.1016/j.ijpharm.2009.09.027 Wheatley, 1995, Structural studies on stabilized microbubbles: development of a novel contrast agent for diagnostic ultrasound, React. Polym., 25, 157, 10.1016/0923-1137(94)00039-8 Wheatley, 2006, Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging, Ultrasound Med. Biol., 32, 83, 10.1016/j.ultrasmedbio.2005.08.009